Knight Therapeutics Responds to Shareholder Discontent By Targeting Medison Biotech, Knight’s Second Largest Shareholder
March 15, 2019 07:40 ET
|
Medison Biotech Ltd.
Hours after Medison delivers stinging rebuke of Knight’s lack of vision and execution, Knight’s lawyers and accountants deliver onerous data demands to Medison on specious groundsKnight’s expensive...
Knight Therapeutics’ Second Largest Shareholder Presents Strategy to Create Shareholder Value
March 14, 2019 08:00 ET
|
Medison Biotech Ltd.
Strategic plan built around becoming the partner of choice for “rest of world” commercialization of highly innovative biotech products with blockbuster potentialPlan expected to generate CAD$500...
Second Largest Knight Therapeutics Shareholder Submits Proposal to Amend Bylaws to Address Conflicts of Interest at Board and Management Level
March 08, 2019 09:51 ET
|
Medison Biotech Ltd.
Medison Biotech makes shareholder proposal to effect governance reform after a number of significant Knight shareholders express grave concerns over Board and management conflicts of interest ...
Second Largest Knight Therapeutics Shareholder Calls for Substantial Change
February 28, 2019 08:00 ET
|
Medison Biotech Ltd.
Medison Biotech sends open letter to Knight Board of DirectorsLetter highlights Knight’s lack of strategic vision and poor execution as well as CEO’s significant conflicts of interest and the Board’s...